[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EE9700105A - Cisapriidi suu kaudu manustatavad pikendatud vallandumismehhanismiga kompositsioonid - Google Patents

Cisapriidi suu kaudu manustatavad pikendatud vallandumismehhanismiga kompositsioonid

Info

Publication number
EE9700105A
EE9700105A EE9700105A EE9700105A EE9700105A EE 9700105 A EE9700105 A EE 9700105A EE 9700105 A EE9700105 A EE 9700105A EE 9700105 A EE9700105 A EE 9700105A EE 9700105 A EE9700105 A EE 9700105A
Authority
EE
Estonia
Prior art keywords
sustained release
release mechanism
oral compositions
cisapride
cisapride oral
Prior art date
Application number
EE9700105A
Other languages
English (en)
Other versions
EE03510B1 (et
Inventor
Marie Josef Jans Eugene
Marie Victor Gilis Paul
Original Assignee
Janssen Pharmaceutica N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica N.V. filed Critical Janssen Pharmaceutica N.V.
Publication of EE9700105A publication Critical patent/EE9700105A/et
Publication of EE03510B1 publication Critical patent/EE03510B1/et

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4468Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cereal-Derived Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
EE9700105A 1994-11-02 1995-10-25 Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine EE03510B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP94203184 1994-11-02
PCT/EP1995/004198 WO1996014070A1 (en) 1994-11-02 1995-10-25 Cisapride extended release oral compositions

Publications (2)

Publication Number Publication Date
EE9700105A true EE9700105A (et) 1997-12-15
EE03510B1 EE03510B1 (et) 2001-10-15

Family

ID=8217338

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9700105A EE03510B1 (et) 1994-11-02 1995-10-25 Tsisapriidi pikendatud vabastamisega ravimvorm suukaudseks manustamiseks, selle valmistamine ja kasutamine

Country Status (29)

Country Link
US (2) US6153623A (et)
EP (1) EP0789572A1 (et)
JP (1) JP3182423B2 (et)
KR (1) KR100255521B1 (et)
AP (1) AP658A (et)
AR (1) AR001765A1 (et)
AU (1) AU704284B2 (et)
BG (1) BG63244B1 (et)
BR (1) BR9509565A (et)
CA (1) CA2203663C (et)
CZ (1) CZ287844B6 (et)
EE (1) EE03510B1 (et)
FI (1) FI971856A0 (et)
HR (1) HRP950539A2 (et)
HU (1) HUT77887A (et)
IL (1) IL115843A0 (et)
MY (1) MY113092A (et)
NO (1) NO312538B1 (et)
NZ (1) NZ295166A (et)
OA (1) OA10419A (et)
PL (1) PL181470B1 (et)
RO (1) RO116042B1 (et)
RU (1) RU2143890C1 (et)
SK (1) SK54297A3 (et)
TR (1) TR199501351A2 (et)
TW (1) TW466114B (et)
UA (1) UA50721C2 (et)
WO (1) WO1996014070A1 (et)
ZA (1) ZA959221B (et)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release
WO1997020562A1 (en) * 1995-12-01 1997-06-12 Janssen Pharmaceutica N.V. Cisapride sustained release
ATE220543T1 (de) * 1996-04-23 2002-08-15 Janssen Pharmaceutica Nv Rasch-freisetzende ph-unabhängige feste dosisformen enthaltend cisaprid
CA2275604A1 (en) * 1997-01-03 1998-07-09 Kenneth Iain Cumming Sustained release cisapride mini-tablet formulation
WO1998056364A1 (en) * 1997-06-11 1998-12-17 Janssen Pharmaceutica N.V. IMMEDIATE RELEASE pH-INDEPENDENT SOLID DOSAGE FORM OF (+)- OR (-)-CISAPRIDE
TW407058B (en) * 1998-07-17 2000-10-01 Dev Center Biotechnology Oral cisapride dosage forms with an extended duration
PL198797B1 (pl) * 1999-03-31 2008-07-31 Janssen Pharmaceutica Nv Zastosowanie wstępnie żelowanej skrobi
EP1060743A1 (en) * 1999-06-17 2000-12-20 Development Center For Biotechnology Oral cisapride dosage forms with an extended duration
PT1345595E (pt) * 2000-09-29 2007-08-13 Solvay Pharm Bv Formulação farmacêutica de libertação prolongada independente da força iónica
DE60228939D1 (de) * 2002-05-21 2008-10-30 Watson Lab Inc Pharmazeutische Zusammensetzung mit verzögerter Freisetzung
WO2007123021A1 (ja) 2006-04-12 2007-11-01 Nippon Soda Co., Ltd. 徐放性錠剤の製造方法
RU2356532C2 (ru) * 2007-06-01 2009-05-27 Открытое Акционерное Общество "Отечественные Лекарства" Фармацевтическая композиция проксодолола с контролируемым высвобождением
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1183847A (en) * 1981-10-01 1985-03-12 Georges Van Daele N-(3-hydroxy-4-piperidinyl)benzamide derivatives
US5057525A (en) * 1981-10-01 1991-10-15 Janssen Pharmaceutica N.V. Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives
WO1993018755A1 (en) * 1992-03-25 1993-09-30 Depomed Systems, Incorporated Alkyl-substituted cellulose-based sustained-release oral drug dosage forms
WO1994001112A1 (en) * 1992-07-07 1994-01-20 Sepracor Inc. Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders
ZA959221B (en) * 1994-11-02 1997-04-30 Janssen Pharmaceutica Nv Cisapride extended release

Also Published As

Publication number Publication date
BG101401A (en) 1997-12-30
AU704284B2 (en) 1999-04-15
NO971832D0 (no) 1997-04-21
AR001765A1 (es) 1997-12-10
SK54297A3 (en) 1997-10-08
EP0789572A1 (en) 1997-08-20
EE03510B1 (et) 2001-10-15
CZ287844B6 (en) 2001-02-14
IL115843A0 (en) 1996-01-31
PL319948A1 (en) 1997-09-01
AU3844795A (en) 1996-05-31
MX9703249A (es) 1997-07-31
WO1996014070A1 (en) 1996-05-17
KR100255521B1 (ko) 2000-05-01
US6274599B1 (en) 2001-08-14
NO312538B1 (no) 2002-05-27
CA2203663A1 (en) 1996-05-17
AP658A (en) 1998-08-17
TW466114B (en) 2001-12-01
US6153623A (en) 2000-11-28
BG63244B1 (bg) 2001-07-31
BR9509565A (pt) 1997-09-16
HUT77887A (hu) 1998-09-28
TR199501351A2 (tr) 1996-06-21
JP3182423B2 (ja) 2001-07-03
PL181470B1 (pl) 2001-07-31
ZA959221B (en) 1997-04-30
NO971832L (no) 1997-04-21
FI971856A (fi) 1997-04-30
CA2203663C (en) 2002-04-30
FI971856A0 (fi) 1997-04-30
UA50721C2 (uk) 2002-11-15
NZ295166A (en) 1999-03-29
AP9700969A0 (en) 1997-04-30
MY113092A (en) 2001-11-30
JPH09511760A (ja) 1997-11-25
HRP950539A2 (en) 1997-08-31
RU2143890C1 (ru) 2000-01-10
RO116042B1 (ro) 2000-10-30
CZ124497A3 (en) 1997-08-13
OA10419A (en) 2001-12-06

Similar Documents

Publication Publication Date Title
FI963421A0 (fi) Oraalisia apuainekoostumuksia
ID20233A (id) Komposisi oral
DE69529254D1 (de) Hebelmechanismus
GB2322632B (en) A toilet block composition
BR9508844A (pt) Composição oral
EP0948955A4 (en) POLYMERIZABLE COMPOSITION FOR DENTAL APPLICATIONS
FI961436A (fi) Suun kautta annettavia sienilääkekoostumuksia
BR9506536A (pt) Composição oral
SG80626A1 (en) A photo resist composition
EE9700105A (et) Cisapriidi suu kaudu manustatavad pikendatud vallandumismehhanismiga kompositsioonid
DK1023035T3 (da) Mundplejemiddel
BR9510467A (pt) Composições orais
DE69509945D1 (de) Formmechanismus
ID20466A (id) Komposisi oral
NO993944L (no) Utlösermekanisme
BR9510307A (pt) Composições orais
DK0664212T3 (da) Trykkeanlæg med en bevægelig trykkeenhed
DE69509946D1 (de) Formmechanismus
IL126933A0 (en) A disinfectant composition
ID19246A (id) Komposisi oral antikalkulus
GB9906837D0 (en) A gypsum composition
ID19099A (id) Komposisi oral
BR9510459A (pt) Composições orais
FIU960240U0 (fi) Lukituslaite
GB9916754D0 (en) A composition

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

MM4A Lapsed by not paying the annual fees

Effective date: 20041025